IL160894A0 - Combination of selected opioids with muscarine antagonists for treating urinary incontinence - Google Patents

Combination of selected opioids with muscarine antagonists for treating urinary incontinence

Info

Publication number
IL160894A0
IL160894A0 IL16089402A IL16089402A IL160894A0 IL 160894 A0 IL160894 A0 IL 160894A0 IL 16089402 A IL16089402 A IL 16089402A IL 16089402 A IL16089402 A IL 16089402A IL 160894 A0 IL160894 A0 IL 160894A0
Authority
IL
Israel
Prior art keywords
urinary incontinence
combination
treating urinary
opioids
muscarine antagonists
Prior art date
Application number
IL16089402A
Other languages
English (en)
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of IL160894A0 publication Critical patent/IL160894A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL16089402A 2001-09-18 2002-09-18 Combination of selected opioids with muscarine antagonists for treating urinary incontinence IL160894A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10146275A DE10146275A1 (de) 2001-09-18 2001-09-18 Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz
PCT/EP2002/010460 WO2003024444A1 (fr) 2001-09-18 2002-09-18 Combinaison d'opioides selectionnes et d'antagonistes de muscarine destinee a traiter l'incontinence urinaire

Publications (1)

Publication Number Publication Date
IL160894A0 true IL160894A0 (en) 2004-08-31

Family

ID=7699618

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16089402A IL160894A0 (en) 2001-09-18 2002-09-18 Combination of selected opioids with muscarine antagonists for treating urinary incontinence
IL160894A IL160894A (en) 2001-09-18 2004-03-16 Combination of selected opioids with muscarine antagonists for treating urinary incontinence

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL160894A IL160894A (en) 2001-09-18 2004-03-16 Combination of selected opioids with muscarine antagonists for treating urinary incontinence

Country Status (22)

Country Link
US (2) US20040242617A1 (fr)
EP (1) EP1429754B1 (fr)
JP (1) JP4511176B2 (fr)
KR (1) KR100891438B1 (fr)
CN (1) CN100384413C (fr)
AT (1) ATE383854T1 (fr)
AU (1) AU2002342707B2 (fr)
BR (1) BR0212714A (fr)
CA (1) CA2460655C (fr)
DE (2) DE10146275A1 (fr)
EC (1) ECSP045025A (fr)
ES (1) ES2299608T3 (fr)
HK (1) HK1075205A1 (fr)
HU (1) HUP0401485A3 (fr)
IL (2) IL160894A0 (fr)
MX (1) MXPA04002510A (fr)
NO (1) NO333016B1 (fr)
NZ (1) NZ531777A (fr)
PL (1) PL209272B1 (fr)
RU (1) RU2305562C2 (fr)
WO (1) WO2003024444A1 (fr)
ZA (1) ZA200402853B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10146275A1 (de) 2001-09-18 2003-04-24 Gruenenthal Gmbh Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz
DE10224108A1 (de) * 2002-05-29 2004-01-29 Grünenthal GmbH 1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol enthaltendes Arzneimiitel mit verzögerter Wirkstofffreisetzung
US7410965B2 (en) 2002-05-29 2008-08-12 Gruenenthal Gmbh Delayed release pharmaceutical composition containing 1-dimethyl-amino-3-(3-methoxyphenyl)-2-methyl-pentan-3-ol
DE10224556A1 (de) * 2002-05-31 2004-01-08 Grünenthal GmbH 1-Dimethylamino- 3-(3-methoxy-phenyl)2-methyl-pentan-3-ol entaltendes Arzneimittel in verschiedenen Formulierungen
AU2003301184A1 (en) * 2002-12-20 2004-07-22 Dynogen Pharmaceuticals Inc METHODS OF TREATING NON-PAINFUL BLADDER DISORDERS USING Alpha2Delta SUBUNIT CALCIUM CHANNEL MODULATORS
DE602004003172T2 (de) * 2003-03-21 2007-09-27 Dynogen Pharmaceuticals Inc., Waltham Verfahren zur behandlung von erkrankungen der unteren harnwege mit antimuskarinika und mit modulatoren der alpha-2-delta untereinheit des kalziumkanals
DE10356362A1 (de) * 2003-11-28 2005-06-23 Grünenthal GmbH Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie von Angststörungen
CA2566601C (fr) * 2004-05-14 2013-04-09 Janssen Pharmaceutica N.V. Composes carboxamido opioides
DE102005009217A1 (de) * 2005-02-25 2006-08-31 Grünenthal GmbH Phosphatsalze der 6-Dimethylaminomethyl-1-(3-methoxyphenyl)-1,3-dihydroxy-cyclohexanverbindungen
US20070032551A1 (en) * 2005-07-22 2007-02-08 Gruenenthal Gmbh Salt of dimethylaminomethyl-phenyl-cyclohexane and crystalline forms thereof
US7884247B2 (en) * 2005-07-22 2011-02-08 Gruenenthal Gmbh Salt of dimethylaminomethyl-phenyl-cyclohexane and crystalline forms thereof
EP2336103A3 (fr) * 2005-07-22 2011-07-20 Grünenthal GmbH Polymorphes HCL du 3-[2-(diméthylamino)méthyl-(cyclohex-1-yl)]phénol
DE102007022790A1 (de) 2007-05-11 2008-11-20 Grünenthal GmbH Axomadol zur Schmerzbehandlung bei Arthrose
PE20190391A1 (es) * 2008-10-30 2019-03-13 Gruenenthal Chemie Formas de dosificacion del tapentadol novedosas y potentes
WO2011110595A1 (fr) 2010-03-10 2011-09-15 Grünenthal GmbH Sels cristallins et/ou co-cristaux de o-desméthyltramadol
KR101858797B1 (ko) 2010-05-10 2018-05-16 유로-셀티큐 에스.에이. 히드로모르폰 및 날록손을 포함하는 제약 조성물
MX344846B (es) 2010-05-10 2017-01-10 Euro-Celtique S A * Combinacion de granulos cargados activos con activos adicionales.
KR20130030261A (ko) 2010-05-10 2013-03-26 유로-셀티큐 에스.에이. 활성제-무함유 과립 및 그를 포함하는 정제의 제조
CN103040828B (zh) * 2013-01-07 2015-12-02 常州康普药业有限公司 复方地芬诺酯片及其制备方法
EA030310B1 (ru) 2013-11-13 2018-07-31 Эро-Селтик С.А. Гидроморфон и налоксон для лечения боли и индуцированного опиоидами синдрома дисфункции кишечника
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB857194A (en) * 1957-07-05 1960-12-29 Clinical Products Ltd Therapeutic agents comprising ion-exchange resins
NL127065C (fr) 1964-04-22
US5736577A (en) 1995-01-31 1998-04-07 Sepracor, Inc. Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
DE3012837A1 (de) * 1979-04-10 1980-10-30 Sandoz Ag Analgetische und myotonolytische praeparate
DE3129982A1 (de) * 1981-07-29 1983-02-17 Jutta 8200 Rosenheim Meyer "antiallergikum"
US5073560A (en) 1990-07-20 1991-12-17 Fisons Corporation Spiro-isoxazolidine derivatives as cholinergic agents
DE4041559A1 (de) 1990-12-22 1992-06-25 Boehringer Ingelheim Kg Neue wirkstoffkombinationen
DE4426245A1 (de) 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
ES2214532T3 (es) * 1995-03-03 2004-09-16 Endo Pharmaceuticals Inc. Uso de dextrorfano o dextrometorfano para el tratamiento de la incontinencia urinaria.
DE19525137C2 (de) 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
DE19609847A1 (de) * 1996-03-13 1997-09-18 Gruenenthal Gmbh Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe
EP0924983A4 (fr) 1996-07-19 1999-08-25 Gunnar Aberg S(-)-tolterodine pour le traitement des troubles urinaires et gastro-intestinaux
WO1998046216A1 (fr) * 1997-04-11 1998-10-22 Nippon Shinyaku Co., Ltd. Traitements des mictions frequentes et de l'incontinence urinaire
PE20010623A1 (es) 1999-10-05 2001-07-07 Gruenenthal Chemie Uso de (+)-tramadol y/o o-demetiltramadol para tratamiento de urgencia urinaria incrementada y/o incontinencia urinaria
CN1660435A (zh) * 2000-02-24 2005-08-31 法玛西雅厄普约翰美国公司 新的药物联合形式
DE10059412A1 (de) * 2000-11-30 2002-06-13 Gruenenthal Gmbh Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie der Harninkontinenz
DE10146275A1 (de) 2001-09-18 2003-04-24 Gruenenthal Gmbh Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz

Also Published As

Publication number Publication date
HUP0401485A3 (en) 2008-04-28
MXPA04002510A (es) 2004-05-31
KR20040044953A (ko) 2004-05-31
US20120016023A1 (en) 2012-01-19
RU2004111788A (ru) 2005-06-10
US8946290B2 (en) 2015-02-03
ATE383854T1 (de) 2008-02-15
IL160894A (en) 2010-04-29
JP2005507387A (ja) 2005-03-17
PL209272B1 (pl) 2011-08-31
US20040242617A1 (en) 2004-12-02
WO2003024444A1 (fr) 2003-03-27
EP1429754B1 (fr) 2008-01-16
CN100384413C (zh) 2008-04-30
NO20041059L (no) 2004-05-12
CA2460655A1 (fr) 2003-03-27
CN1589140A (zh) 2005-03-02
ECSP045025A (es) 2004-04-28
PL369235A1 (en) 2005-04-18
BR0212714A (pt) 2004-08-03
NZ531777A (en) 2006-11-30
DE50211566D1 (de) 2008-03-06
AU2002342707B2 (en) 2006-10-12
KR100891438B1 (ko) 2009-04-03
EP1429754A1 (fr) 2004-06-23
ES2299608T3 (es) 2008-06-01
RU2305562C2 (ru) 2007-09-10
DE10146275A1 (de) 2003-04-24
HUP0401485A2 (hu) 2004-11-29
JP4511176B2 (ja) 2010-07-28
NO333016B1 (no) 2013-02-18
ZA200402853B (en) 2005-02-23
HK1075205A1 (en) 2005-12-09
CA2460655C (fr) 2012-02-07

Similar Documents

Publication Publication Date Title
HK1075205A1 (en) Combination of selected opioids with muscarine antagonists for treating urinary incontinence
BR0114799A (pt) Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
WO2006066879A3 (fr) Composes inter-reagissant avec des canaux ioniques, en particulier avec des canaux ioniques de la famille kv
EP1933833B8 (fr) Therapie pour le traitement de la vessie hyperactive
DE60041976D1 (de) Phenoxycarbonsäureverbindungen und zusammensetzungen zur verabreichung aktiver wirkstoffe
CA2366702A1 (fr) Compositions et procedes d'administration amelioree d'agents therapeutiques hydrophobes ionisables
YU71901A (sh) NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
WO2006093348A3 (fr) Procede et composition destines au traitement des maladies vasculaires peripheriques
EA200800161A1 (ru) Новые фармацевтические композиции с модифицированным высвобождением и способ получения таких композиций
MY125414A (en) Aminopropylphosphinic acids
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
EP2767291A3 (fr) Traitement d'une glycogénose de type II
DE60134245D1 (de) (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
HK1047707A1 (zh) (+)-曲馬朵、o-去甲曲馬朵或(+)-o-去甲曲馬朵、o-去甲-n-單-去甲-曲馬朵或(+)-o-去甲-n-單-去甲-曲馬朵治療尿失禁的用途
IL162384A0 (en) Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases
TW200501963A (en) Pharmaceutical compositions comprising epinastine for the treatment of skin diseases
BR0315247A (pt) Composição, composição farmacêutica, método de tratamento para uma doença proliferativa celular, e, kit
EP1801232A4 (fr) Procédé de triage d'une substance inhibitrice d'enzyme transmembrane
AU2001246388A1 (en) Controlled release pharmaceutical composition containing midodrine and/or desglymidodrine
WO2002055022A3 (fr) Metabolite actif de compose antifongique
HK1061355A1 (en) Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
PT1337246E (pt) Utilizacao de compostos de 6-dimetilaminometil-1-fenilciclohexano para terapia da incontinencia urinaria
WO2002072098A8 (fr) Methode de traitement
MY141756A (en) Use of phenoxyacetic acid derivatives for treating hyperactive bladder
MX2007007391A (es) Compuestos que interactuan con canales de iones, en particular con canales de iones de la familia kv.